Loading...
Loading...
ABT| Name | Value |
|---|---|
| Revenues | 10.4B |
| Cost of Revenue | 4.6B |
| Gross Profit | 5.8B |
| Operating Expense | 4.1B |
| Operating I/L | 1.7B |
| Other Income/Expense | -0.1B |
| Interest Income | 0.1B |
| Pretax | 1.6B |
| Income Tax Expense | 0.3B |
| Net Income/Loss | 1.3B |
Abbott Laboratories is a global healthcare company that operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company manufactures and sells a wide range of health care products, including generic pharmaceuticals, laboratory systems, molecular diagnostics, nutritional products, rhythm management devices, electrophysiology devices, heart failure devices, vascular devices, structural heart devices, diabetes care products, and neuromodulation devices. Abbott Laboratories generates revenue by providing essential healthcare solutions for various medical needs, such as treatment for cardiovascular diseases, chronic pain management, infectious diseases, and nutritional support for pediatric and adult patients.
